Key result
Transendocardial delivery of autologous bone marrow mononuclear cells improved functional capacity and left ventricular function in patients with chronic heart failure.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Supports transendocardial autologous bone marrow cell therapy in chronic HF; extends randomized cell therapy evidence to this delivery method.
Perin et al. (2012) studied this question. Transendocardial delivery of autologous bone marrow mononuclear cells improved functional capacity and left ventricular function in patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: